Patient initiation and maintenance of GLP-1 RAs for treatment of obesity: a narrative review and practical considerations for primary care providers
Author:
Affiliation:
1. Endocrine Unit, Division of Endocrinology, Department of Medicine and MGH Weight Center, Massachusetts General Hospital, Boston, MA, USA
2. Harvard Medical School, Boston, MA, USA
3. Arizona Obesity Organization, Phoenix, AZ, USA
Funder
Novo Nordisk Inc
Publisher
Informa UK Limited
Subject
General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/00325481.2020.1845534
Reference73 articles.
1. Obesity as a Disease: The Obesity Society 2018 Position Statement
2. American Medical Association. 2012 Resolutions. 2012. Cited Jul 2020. Available from: https://www.ama-assn.org/sites/ama-assn.org/files/corp/media-browser/public/hod/a12-resolutions_0.pdf.
3. Perceptions of Barriers to Effective Obesity Care: Results from the National ACTION Study
4. Trends in Obesity and Severe Obesity Prevalence in US Youth and Adults by Sex and Age, 2007-2008 to 2015-2016
5. Food and Drug Administration. Guidance for industry developing products for weight management. 2007. Cited Jul 2020. Available from: https://www.fda.gov/media/71252/download.
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Intranasal delivery of glucagon-like peptide-1 to the brain for obesity treatment: opportunities and challenges;Expert Opinion on Drug Delivery;2024-07-02
2. GLP-1 Receptor Agonists in Obese Patients with Inflammatory Bowel Disease: from Molecular Mechanisms to Clinical Considerations and Practical Recommendations for Safe and Effective Use;Current Obesity Reports;2023-04-21
3. Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with Glp-1 Receptor Agonists: A Multidisciplinary Expert Consensus;Journal of Clinical Medicine;2022-12-24
4. Association of the gallbladder or biliary diseases with dipeptidyl peptidase 4 inhibitors in patients with type 2 diabetes: a meta-analysis of randomized controlled trials;Diabetology & Metabolic Syndrome;2022-10-21
5. Reframing the need for exercise therapy in the clinical management of people living with obesity;Clinical Obesity;2022-09-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3